Literature DB >> 9564808

Interferon-gamma promotes exaggerated cytokine production in keratinocytes cultured from patients with atopic dermatitis.

S Pastore1, S Corinti, M La Placa, B Didona, G Girolomoni.   

Abstract

Recent studies suggest that skin keratinocytes from patients with atopic dermatitis (AD) and nonatopic subjects differ in their intrinsic ability to respond to proinflammatory stimuli. In this study keratinocyte cultures established from the normal-looking skin of six adult patients with AD and six healthy, nonatopic control subjects were compared in their response to interferon (IFN)-gamma, a potent proinflammatory lymphokine whose expression is increased in chronic AD lesions. Basal expression of IFN-gamma receptor as well as IFN-gamma-induced membrane expression of HLA-DR and intercellular adhesion molecule (ICAM)-1 were evaluated by flow cytometry. Keratinocyte release of IL-1alpha, IL-1 receptor antagonist (IL-1ra), granulocyte-macrophage colony stimulating factor (GM-CSF), and tumor necrosis factor (TNF)-alpha were measured by ELISA on culture supernatants after treatment with IFN-gamma or medium alone. Expression of membrane IFN-gamma receptor was similar in keratinocytes cultured from nonatopic subjects and subjects with AD. IFN-gamma (10 to 500 U/ml) induced comparable levels of membrane HLA-DR and ICAM-1 in both groups of keratinocytes. In contrast, spontaneous release of IL-1alpha, IL-1ra, GM-CSF, and TNF-alpha was increased in the supernatants of unstimulated keratinocytes from patients with AD compared with keratinocytes from control subjects, with IL-1ra and GM-CSF reaching statistically significant difference. Moreover, IFN-gamma-induced release of all the cytokines tested was much higher for keratinocytes from patients with AD, but the IL-1ra/IL-1alpha ratio for the two groups of keratinocytes was not substantially different, either basally or after IFN-gamma stimulation. The results indicate that keratinocytes from patients with AD are hyperresponsive to IFN-gamma in terms of cytokine release.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9564808     DOI: 10.1016/S0091-6749(98)70361-6

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  7 in total

1.  Epithelial cells and atopic diseases.

Authors:  G Girolomoni; S Pastore
Journal:  Curr Allergy Asthma Rep       Date:  2001-11       Impact factor: 4.806

2.  Pleiotropic effects of corticotropin releasing hormone on normal human skin keratinocytes.

Authors:  M E Quevedo; A Slominski; W Pinto; E Wei; J Wortsman
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-01       Impact factor: 2.416

3.  Role of staphylococcal superantigen in atopic dermatitis: influence on keratinocytes.

Authors:  Kyu Han Kim; Ji Hyun Han; Jin Ho Chung; Kwang Hyun Cho; Hee Chul Eun
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

4.  A Pilot Study To Establish an Ovalbumin-induced Atopic Dermatitis Minipig Model.

Authors:  Young Kyu Kim; Ju Young Lee; Jeong Ho Hwang; Han Na Suh
Journal:  J Vet Res       Date:  2021-08-19       Impact factor: 1.744

Review 5.  Cellular aspects of atopic dermatitis.

Authors:  Liang-Shiou Ou; Jing-Long Huang
Journal:  Clin Rev Allergy Immunol       Date:  2007-12       Impact factor: 10.817

6.  IFN-γ Reduces Epidermal Barrier Function by Affecting Fatty Acid Composition of Ceramide in a Mouse Atopic Dermatitis Model.

Authors:  Hiroyuki Kanoh; Asako Ishitsuka; Etsuko Fujine; Shuhei Matsuhaba; Mitsuhiro Nakamura; Hiroyasu Ito; Naoki Inagaki; Yoshiko Banno; Mariko Seishima
Journal:  J Immunol Res       Date:  2019-01-29       Impact factor: 4.818

Review 7.  Immune surveillance in the skin: mechanisms and clinical consequences.

Authors:  Thomas S Kupper; Robert C Fuhlbrigge
Journal:  Nat Rev Immunol       Date:  2004-03       Impact factor: 53.106

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.